Net Loss Per Share (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Net Loss Per Share [Abstract]

Schedule of Basic and Diluted Net Loss Per Share

The following table provides the computation of the basic and diluted net loss per share during the three and nine months ended September 30, 2025 and 2024 (in thousands, except share and per share data):

		Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
Numerator:
Net loss		$	(4,029	)		$	(7,201	)		$	(12,432	)		$	(19,111	)
Denominator:
Weighted average shares used in computing net loss per share, basic and diluted			851,090				681,634				781,461				573,300

Net loss per share, basic and diluted		$	(4.73	)		$	(10.56	)		$	(15.91	)		$	(33.34	)

The following table computes the computation of the basic and diluted net loss per share attributable to common stockholders during the years ended December 31, 2024 and 2023 is as follows (in thousands, except share and per share data):

		Year Ended December 31,
		2024				2023
Numerator:
Net loss		$	(23,727	)		$	(29,283	)
Denominator:
Weighted average shares used in computing net loss per share, basic and diluted			602,333				307,969
Net loss per share, basic and diluted		$	(39.39	)		$	(95.09	)

Schedule of Common Stock Diluted Net Loss Per Share

The potential shares of common stock that were excluded from the computation of diluted net loss per share for the nine months ended September 30, 2025 and 2024 because including them would have been antidilutive are as follows:

		Nine Months Ended September 30,
		2025		2024
Shares subject to options to purchase common stock		69,741		75,511
Shares subject to restricted stock units		150,848		—
Shares subject to warrants to purchase common stock		329,322		335,523
Total		549,911		411,034

The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the years ended December 31, 2024 and 2023 because including them would have been antidilutive are as follows:

		Year Ended December 31,
		2024		2023
Shares subject to options to purchase common stock		72,140		49,656
Shares subject to warrants to purchase common stock		335,523		31,728
Total		407,663		81,384